This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Medigene AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.233. Medigene AG's 10-Year median PS Ratio is 11.3305. Therefore, the Median PS Value for today is €2.64.
As of today (2024-05-24), Medigene AG's share price is €1.20. Medigene AG's Median PS Value is €2.64. Therefore, Medigene AG's Price to Median PS Value for today is 0.45.
The historical rank and industry rank for Medigene AG's Median PS Value or its related term are showing as below:
XTER:MDG1'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14 Med: 0.59 Max: 3.64
Current: 0.45
During the past 13 years, the highest Price to Median PS Value of Medigene AG was 3.64. The lowest was 0.14. And the median was 0.59.
XTER:MDG1's Price-to-Median-PS-Value is ranked better than 67.82% of 261
companies
in the Biotechnology industry
Industry Median: 0.68
vs XTER:MDG1: 0.45
Medigene AG Median PS Value Historical Data
The historical data trend for Medigene AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medigene AG's Median PS Value
For the Biotechnology subindustry, Medigene AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medigene AG's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medigene AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medigene AG's Price-to-Median-PS-Value falls into.
Medigene AG Median PS Value Calculation
Medigene AG's Median PS Value for today is calculated as
10-Year Median PS Ratio is 11.3305.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medigene AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.233.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medigene AG (XTER:MDG1) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medigene AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1.20
/
2.64
=
0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medigene AG Median PS Value Related Terms
Thank you for viewing the detailed overview of Medigene AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:MDG1 has been successfully added to your 